OneOncology is entering a new partnership with Arizona Blood & Cancer Specialists, a newly formed oncology group.
OneOncology has announced that it is entering a new partnership with Arizona Blood & Cancer Specialists, a newly formed oncology group. The new addition marks the fourth group to join the OneOncology network, which currently comprises of 227 physicians across 62 sites of care, and expands the network to the southwest. On June 3, Arizona Blood & Cancer Specialists will open 6 clinics in Tuscon, Green Valley, Nogales, and Safford. Together with OneOncology, the group will build multidisciplinary, comprehensive cancer centers to offer high-quality, personalized care across the continuum, from prevention and diagnosis, to clinical trials, and through survivorship, palliative, and supportive care
"The addition of these expert oncologists to our partnership demonstrates why our physician-led, data-driven, technology-powered, and patient-centric business model is attractive to top doctors across the country," said Tracy L. Bahl, president and chief executive officer of OneOncology.
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More